GlycoLite™ is a proprietary glycoprotein complex
(PHC PV 101) made from white kidney beans that has been clinically proven to block complex carbohydrates from being absorbed in the body. In fact, GlycoLite™’s carb blocking efficacy reduces up to 25% of calories from a standard meal by blocking carbohydrate absorption. GlycoLite™ works without pharmacological, immunological or metabolic effect on the human body.
The reduction of carbohydrate absorption also lowers plasma glucose levels and reduces insulin secretion. This helps manage food cravings, which can also support weight management.
GlycoLite™ is the result of extensive R&D and a long process of scientific validation of its safety and efficacy. GlycoLite™ is extracted through a proprietary process and undergoes stringent quality controls that ensure optimum efficacy and total traceability. Every batch of GlycoLite™ is certified to conform to the required specifications to ensure consumer safety and to preserve the optimum carb blocking capacity.
GlycoLite™ is an effective tool for weight management, as it works mechanically, without exerting systemic effects on the human body. As a result of this mode of action, products made with GlycoLite™ are certified as a medical device under the EU Medical Device Directive 93/42/EEC.
GlycoLite™ is a trademark of Prosanita Healthcare Limited. GlycoLite™ is exclusively manufactured and distributed worldwide by Prosanita Healthcare Limited.